Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)

Clinical trial NCT05893381 · RECRUITING

Trial details

NCT number: NCT05893381
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2023-06-27
Primary completion: 2027-09-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.